Search Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapyPediatric Oncology and HematologyProtocol groupLeukemias (ped.)radiotherapyDiseaseAcute Lymphoblastic LeukaemiaMalignant MeningitisSubgroupB-ALLLeukemic MeningitisT-ALLICD10C79.3C91.0-MeSHMeningeal CarcinomatosisPrecursor B-Cell Lymphoblastic Leukemia-LymphomaSequenceChemotherapyChemo-substanceMercaptopurineMethotrexateChemo-substanceMercaptopurineMethotrexateChemo-substanceMercaptopurineMethotrexateChemo-substanceMercaptopurineMethotrexateNo. Substances2 RadiotherapySupportive therapySupportive substanceCotrimoxazoleSupportive substanceCotrimoxazoleSupportive substanceCotrimoxazoleSupportive substanceCotrimoxazoleNo. Substances1Protocol classificationTherapy classificationStudy protocol, currentIntensityStandard doseTherapy indicationFirst lineTherapy phaseTherapy intentioncurativeRisks only studiesPublicationAuthorHorstmann MDiseaseVorläufer-B- und T-Zell Leukämie, Hochrisiko ALLOriginGesellschaft für Pädiatrische Onkologie und Hämatologie, Studienprotokoll COALL 08-09Protocols in Revision 1 protocol foundProtocols under revision.PAED COALL 08-09, CNS, B-ALL/T-ALL, initial CNS involvement (PID29 V1.0)
